同侧上肢动静脉瘘患者原位胸廓内动脉搭桥的手术结局
本研究回顾性分析2家机构2015年2月至2023年12月接受CABG的透析依赖患者,最终队列122例,分为同侧原位ITA组66例和对侧原位或游离ITA组56例。中位随访2.4年,主要心脑血管不良事件发生率44%(同侧39% vs 对侧/游离50%,P=.24),3年死亡率29% vs 21%(P=.352),多因素分析未显示ITA-AVF侧别与MACCE或3年死亡相关。结论为同侧原位ITA搭桥未显著增加围术期或长期不良结局,但需更大样本验证。
要点
- 透析依赖合并上肢动静脉瘘患者行CABG时,同侧原位ITA搭桥未显著增加MACCE风险。
- 同侧与对侧/游离ITA组3年死亡率无显著差异(29% vs 21%,P=.352)。
- 围术期并发症如手术部位感染、30天死亡、延长通气无显著差异。
核心结论
- 同侧原位ITA搭桥未显著增加透析依赖上肢动静脉瘘患者的围术期或长期不良结局。
研究设计与样本
- 回顾性队列研究,纳入2家机构2015年2月至2023年12月透析依赖CABG患者,最终队列N=122,同侧原位ITA组66例,对侧原位或游离ITA组56例。
主要发现
- 中位随访2.4年,MACCE发生率44%(同侧39% vs 对侧/游离50%,P=.24)。
- 3年死亡率同侧29% vs 对侧/游离21%(P=.352)。
- 多因素分析显示ITA-AVF侧别与MACCE无关联(调整OR 0.68,P=.31),与3年死亡无关联(调整HR 1.56,P=.291)。
- 围术期手术部位感染、30天死亡、延长通气无显著差异。
临床怎么用
- 对于透析依赖合并上肢动静脉瘘需CABG的患者,同侧原位ITA搭桥可作为考虑选项,但需个体化评估。
局限性
- 样本量中等(N=122)的回顾性队列,结果应视为假设生成性,需更大规模多中心研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The use of in situ internal thoracic artery (ITA) grafts ipsilateral to upper extremity arterio-venous fistulas (UE-AVFs) during coronary artery bypass grafting (CABG) in dialysis-dependent patients raises concerns of coronary steal and compromised graft perfusion. However, the clinical significance of ITA-AVF laterality remains uncertain. METHODS: We retrospectively analysed dialysis-dependent patients who underwent CABG between February 2015 and December 2023 at 2 institutions. Patients with non-UE-AVF access, total vein grafting, or composite vein-artery configurations were excluded. The final cohort (N = 122) was divided into 2 groups: ipsilateral in situ ITA grafts (N = 66) and contralateral in situ or free ITA grafts (N = 56). The primary outcome was the incidence of major adverse cardiovascular and cerebrovascular events (MACCE); secondary outcomes included perioperative complications, haemodialysis-induced ischaemia, and 3-year survival. RESULTS: Baseline and operative characteristics were largely comparable between groups. Perioperative outcomes, including surgical site infection, 30-day mortality, and prolonged ventilation, showed no significant differences. Over a median follow-up of 2.4 years, MACCE occurred in 44% of patients (39% ipsilateral vs 50% contralateral/free ITA; P = .24), with no significant differences in 3-year mortality (29% vs 21%; P = .352). Multivariable analyses showed no association between ITA-AVF laterality and MACCE (adjusted odds ratio 0.68, P = .31) or 3-year mortality (adjusted hazard ratio 1.56, P = .291). CONCLUSIONS: In this modestly sized retrospective cohort, ipsilateral in situ ITA grafting was not associated with significantly worse perioperative or long-term outcomes. Our findings should be interpreted as hypothesis-generating, and larger multicentre studies are needed to more definitively evaluate the safety of this grafting strategy in dialysis-dependent patients with UE-AVFs.
引用
- Chukwudi C, Singh R, Mansur A, et al. Surgical Outcomes of in situ Internal Thoracic Artery Grafting in Patients with Ipsilateral Upper-Extremity Arteriovenous Fistulas. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42644803. doi:10.1093/icvts/ivag231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。